Y.J. Ko
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
Papers in
- Co-authors
- Kelvin Chan (7 shared papers)Vincent C. Tam (3 shared papers)Matthew C. Cheung (2 shared papers)Nicole Mittmann (2 shared papers)Casimir Funk (1 shared paper)Tilman Sauerbruch (1 shared paper)Axel Glasmacher (1 shared paper)J. Mezger (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Current Oncology (10 papers)European Journal of Surgical Oncology (1 paper)The FASEB Journal (1 paper)Clinical Genitourinary Cancer (1 paper)
- Partner nations
- CanadaUnited StatesSouth Korea
In The Last Decade
Y.J. Ko
16 papers receiving 259 citations
Peers
Comparison fields: 5 of 43
- Hepatology 54
- Oncology 173
- Pulmonary and Respiratory Medicine 105
- Surgery 115
- Gastroenterology 11
Countries citing papers authored by Y.J. Ko
This map shows the geographic impact of Y.J. Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y.J. Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y.J. Ko more than expected).
Fields of papers citing papers by Y.J. Ko
This network shows the impact of papers produced by Y.J. Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y.J. Ko. The network helps show where Y.J. Ko may publish in the future.
Co-authors
The 25 scholars most cited alongside Y.J. Ko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 59 | |
| 2 | 2012 | 45 | |
| 3 | 2013 | 44 | |
| 4 | 1998 | 28 | |
| 5 | 2015 | 21 | |
| 6 | 2019 | 13 | |
| 7 | 2014 | 11 | |
| 8 | 2017 | 8 | |
| 9 | 2007 | 8 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 6 | |
| 12 | 2019 | 5 | |
| 13 | 2025 | 4 | |
| 14 | 2018 | 4 | |
| 15 | 2006 | 3 | |
| 16 | 2004 | 2 | |
| 17 | 2025 | 0 |
About Y.J. Ko
Y.J. Ko is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Economics and Econometrics, having authored 17 papers that have together received 268 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Genomics and Diagnostics (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Economic and Financial Impacts of Cancer (2 papers), Renal cell carcinoma treatment (2 papers) and Colorectal and Anal Carcinomas (2 papers). The work is most often cited by research in Hepatology (54 citations), Oncology (173 citations), Pulmonary and Respiratory Medicine (105 citations), Surgery (115 citations) and Gastroenterology (11 citations). Y.J. Ko has collaborated with scholars based in Canada, United States and South Korea. Frequent co-authors include Kelvin Chan, Vincent C. Tam, Matthew C. Cheung, Nicole Mittmann, Casimir Funk, Tilman Sauerbruch, Axel Glasmacher, J. Mezger, Moisés Cukier and Andrew J. Smith. Their work appears in journals such as Journal of Clinical Oncology, Current Oncology, European Journal of Surgical Oncology, The FASEB Journal and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.